Neoadjuvant Immunotherapy: An Evolving Paradigm Shift?
نویسندگان
چکیده
منابع مشابه
Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
[This corrects the article DOI: 10.1186/s40661-015-0020-3.].
متن کاملImmunotherapy in endometrial cancer - an evolving therapeutic paradigm.
Endometrial cancer is the only gynecologic malignancy with a rising incidence and mortality. While cure is routinely achieved with surgery alone or in combination with adjuvant pelvic radiotherapy when disease is confined to the uterus, patients with metastatic or recurrent disease exhibit limited response rates to cytotoxic chemotherapy, targeted agents, or hormonal therapy. Given the unmet cl...
متن کاملVolunteering: an Evolving Paradigm
vital role in preserving the stability and cohesion of societies and makes a significant, but largely overlooked, economic contribution. It also brings considerable benefits to people who have the opportunity to volunteer. Moreover, volunteering helps to widen social, economic and cultural networks, enhances self-esteem, meets the need of people to learn from each other, facilitates acquisition...
متن کاملCancer immunotherapy trials: leading a paradigm shift in drug development
Background Cancer immunotherapy has a long history in the clinic. William Coley was an orthopedic surgeon in the late 1800’s who noted marked tumor regression in a patient with severe erysipelas. Based on this observation, he hypothesized that stimulating the immune system could effectively treat cancer. Thus, over the next decades he gave various bacterial products, including live bacteria, to...
متن کاملHarnessing Ionizing Radiation to Enhance Immunotherapy: A Paradigm Shift
The field of cancer immunotherapy, once the sole purview of immunology, has evolved toward the harnessing of newly described properties of ionizing radiation (IR). Cancer immunotherapy now includes the combination of established cytotoxic modalities with immune manipulations, as vaccines alone are unlikely to succeed at curing bulky, established tumors.[1] Combining chemotherapy with immunother...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI: Journal of the National Cancer Institute
سال: 2021
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/djaa217